10 million adults use GABA analogs gabapentin (Neurontin) or pregabalin (Lyrica) | Analogs linked to dependence, mental impairment, and used in untested combinations | Unwarranted FDA reassurance on pimavanserin (Nuplazid) safety profile.
QuarterWatch™ Reports
An independent perspective on emerging drug risks
QuarterWatch™ is published four times a year as a public service to provide an independent perspective on emerging drug risks. This scientific publication uses as its primary source recently released reports submitted to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS).